Keyphrases
Neuroblastoma
100%
Transcriptional Network
100%
Tumor Phenotype
100%
5-hydroxymethylcytosine (5hmC)
100%
Tumor
33%
Linear Discriminant Analysis
22%
Prognostic Marker
22%
Oncology
22%
Childrens
22%
Epigenetic Modification
22%
High-grade Tumor
22%
High Risk
11%
Hazard Ratio
11%
RNA Sequencing (RNA-seq)
11%
Adult Patients
11%
Gene Expression
11%
Validation Cohort
11%
Inflammation
11%
Hierarchical Clustering
11%
DNA Sequencing
11%
Clinical High Risk
11%
Patients with Cancer
11%
Neuronal Differentiation
11%
Outcome Prediction
11%
Risk Outcomes
11%
Genetic Profile
11%
Diagnostic Biomarker
11%
Whole Genome
11%
PRC2 Complex
11%
DNA Modification
11%
Clinical Behavior
11%
Pediatric Cancer
11%
Discriminant Analysis
11%
Transcriptomic Network
11%
Robust Diagnostics
11%
Clinical Risk Groups
11%
DESeq2
11%
Neuroblastoma Tumor
11%
Neuroscience
Neuroblastoma
100%
5-Hydroxymethylcytosine
100%
Gene Expression
11%
Behavior (Neuroscience)
11%
Nerve Cell Differentiation
11%
Transcriptomics
11%
RNA Sequence
11%
Epigenetic Modification
11%
Biochemistry, Genetics and Molecular Biology
5-Hydroxymethylcytosine
100%
RNA Sequence
11%
Gene Expression
11%
RNA
11%
Nerve Cell Differentiation
11%
KRAS
11%
DNA Modification
11%
Transcriptomics
11%
High Risk Population
11%
PRC2
11%
Epigenetic Modification
11%
Diagnostic Biomarker
11%